You are here

Btk inhibitors

Sanofi's New Cancer Drug Could Help Deliver a Big Payday

Motley Fool

Wed, 05/8/24 - 11:34 am

clinical trials

Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint

Clinical Trials Arena

Tue, 04/23/24 - 10:51 am

Novartis' BTK inhibitor beats placebo in dermatology trial, lining up another potential indication

Fierce Biotech

Sun, 03/10/24 - 08:29 pm

hidradenitis suppurativa

clinical trials

Merck KGaA drops BTK inhibitor evobrutinib, marking end of road for blockbuster dreams

Fierce Biotech

Thu, 03/7/24 - 11:34 am

Eli Lilly’s Jaypirca to dominate CLL BTK inhibitor market by 2032

Biopharma Reporter

Thu, 01/18/24 - 05:04 pm

Lilly Wins Second Accelerated Approval for Reversible BTK Inhibitor

BioSpace

Mon, 12/4/23 - 09:41 am

small lymphocytic leukemia

AbbVie's Imbruvica-Brukinsa patent suit may have merit, and BeiGene will likely settle: expert

Fierce Pharma

Tue, 06/27/23 - 10:21 pm

Merck KGaA's multiple sclerosis drug hit with partial FDA hold, adding to BTK-liver injury links

Fierce Biotech

Wed, 04/12/23 - 11:52 am

multiple sclerosis

Lilly enters ripe BTK field with quick FDA nod in mantle cell lymphoma

Endpoints

Sun, 01/29/23 - 02:14 pm

mantle cell lymphoma

EHA 2019 – turnaround puts Arqule in the takeover frame

EP Vantage

Sat, 06/15/19 - 05:47 pm

Imbruvica resistance provides early but fertile development ground

EP Vantage

Fri, 03/15/19 - 10:43 am

drug development

In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica

Endpoints

Tue, 01/15/19 - 10:08 am

In wake of Eli Lilly setback, Merck KGaA’s leading BTK drug for autoimmune disease clears PhIIb hurdle

Endpoints

Fri, 03/9/18 - 10:48 am

autoimmune disease

$690M deal in peril after Lilly ends mid-stage studies

Biopharma Dive

Wed, 02/21/18 - 09:43 am

clinical trials

rheumatoid arthritis

Hanmi Pharmaceutical

LY3337641/HM71224

Following PhIII breakdown, AstraZeneca cruises toward an FDA decision for its BTK blockbuster hopeful acalabrutinib

Endpoints

Wed, 08/2/17 - 09:50 am

MannKind Rents Out a Drug Program

Motley Fool

Tue, 05/1/12 - 12:37 pm

Pharmacyclics Scores Big With Janssen Biotech Deal

Seeking Alpha

Mon, 12/12/11 - 10:40 am

Janssen Biotech